This carbonyl reducing activity of AKR1B10 decreases the anticancer effectiveness of daunorubicin

This carbonyl reducing activity of AKR1B10 decreases the anticancer effectiveness of daunorubicin. AKR1B10 decreases the anticancer performance of daunorubicin. Similarly, kinetic guidelines Km and kcat (NADPH, DL-glyceraldehyde) for the reduction of dl-glyceraldehyde by wild-type AKR1B10 are 2.20.2mM and 0.710.05sec?1, respectively. Mutation of residue 299 from Cys to Ser in AKR1B10 reduces the protein affinity for … Read more